Oricell Therapeutics is a Biotech company based in Shanghai, China. It has raised $110M in total funding.
Oricell Therapeutics funding overview
Oricell Therapeutics is a Biotech company based in Shanghai, China. Oricell Therapeutics has raised $110M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for Oricell Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include E-Town Capital, Luxin Venture Capital, NGS Super, Vivo Capital, Beijing Medical and Health Care Industry Investment Fund, Qiming Venture Partners. 6 distinct backers are named across the disclosed rounds.
Oricell Therapeutics at a glance
Total raised
$110M
Latest round date
April 2026
Industry
Biotech
Headquarters
Shanghai, China
Notable investors
E-Town Capital, Luxin Venture Capital, NGS Super, Vivo Capital, Beijing Medical and Health Care Industry Investment Fund, Qiming Venture Partners
Frequently asked about Oricell Therapeutics funding
How much has Oricell Therapeutics raised?
Oricell Therapeutics has raised $110M in total disclosed funding across the rounds on record.
Who has invested in Oricell Therapeutics?
E-Town Capital, Luxin Venture Capital, NGS Super, Vivo Capital, Beijing Medical and Health Care Industry Investment Fund, Qiming Venture Partners are named among the investors backing Oricell Therapeutics.
What was the latest Oricell Therapeutics funding round?
No round stage has been disclosed for Oricell Therapeutics.
Where is Oricell Therapeutics based?
Oricell Therapeutics is based in Shanghai, China.
What sector does Oricell Therapeutics operate in?
Oricell Therapeutics is tracked under Biotech from Shanghai, China, with $110M in disclosed funding.
When did Oricell Therapeutics last raise?
The last disclosed Oricell Therapeutics round closed in April 2026.
Every Oricell Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Shanghai at a similar stage.
